Team Lead III
Resolian
Andy Xue is a Team Lead III at Resolian, holding an M.S. in Chemistry. Since joining the company in 2021, he has built a team specializing in method development. Under his leadership, the team has successfully developed assays that overcame significant technical challenges to support the bioanalysis of both preclinical and clinical studies. Their work encompasses a broad range of pharmaceutical modalities, including antibody-drug conjugates (ADCs), peptide-drug conjugates (PDCs), antibody-oligonucleotide conjugates (AOCs), peptides, antibodies, oligonucleotides, and small molecules.